Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FIREFLY NEUROSCIENCE, INC.IAIC · Entity 7759 | Director | July 17, 2017 | July 18, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FIREFLY NEUROSCIENCE, INC.
Report date July 17, 2017 · Filed July 18, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.35 · Expires 2022-07-17 | Direct | 30,000 |
Reported balance
After 2017-07-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-07-17 · Grant · Acquired 5,000 · Balance 30,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 17, 2017 Filed Jul 18, 2017 16:08 UTC | FIREFLY NEUROSCIENCE, INC. IAIC · Entity 7759 | GrantOptions (Right-to-Buy) · Derivative | 5,000 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001654954-17-006512 · section16.xml · derivative · entry 1 WESTER JAMES D · CIK 0001238396 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 5,000 shares Expires 2022-07-17 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.